Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K2 | P36507 | 20/20 | 0.57 |
| ▸ | MAP2K1 | Q02750 | 20/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | BRAF | P15056 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | ACTR3 | P61158 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30220989 | 0.85 | MAP2K1 (0.66) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL1488305 | 0.85 | MAP2K1 (0.66) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL4346597 | 0.84 | MAP2K2 (0.57) | MAP2K2MAP2K1BRAF | |
| Trifluoroacetic Acid SCHEMBL29413409 | 0.81 | MAP2K1 (0.60) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| Trifluoroacetic Acid SCHEMBL1488621 | 0.81 | MAP2K1 (0.60) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL3262393 | 0.79 | MAP2K2 (0.72) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL1488913 | 0.77 | MAP2K1 (0.64) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL30221007 | 0.77 | MAP2K1 (0.64) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL17974842 | 0.77 | MAP2K1 (0.93) | MAP2K2MAP2K1CHRM2CHRM1BRAF | |
| SCHEMBL26114935 | 0.76 | MAP2K2 (0.64) | MAP2K2MAP2K1CHRM2CHRM1BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008124085-A2 | METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS | EXELIXIS, INC. (US) | 2008-10-16 | — | — | WO | disclosed |